Allogene Therapeutics stock forecast 2022 - 2025 - 2030 with analysis
Allogene Therapeutics stock stood at $8.21000003814697 on 2023-02-02. According to latest technical analysis, Allogene Therapeutics stock forecast for 2023 is $10.62, forecast for 2024 is $12.81, forecast for 2025 is $10.76, forecast for 2026 is $8.86, forecast for 2027 is $6.4, forecast for 2028 is $5.52, forecast for 2029 is $10.08, forecast for 2030 is $12.89, forecast for 2031 is $10.6, and forecast for 2032 is $8.86.
| year | Average | Low | High | Change from 2023-02-02 | Avg. Change from previous year |
|---|---|---|---|---|---|
| 2023 | $10.62 | $8.28 | $12.66 | 29.33% | - |
| 2024 | $12.81 | $12.44 | $13.1 | 56.03% | 20.62% |
| 2025 | $10.76 | $9.42 | $12.62 | 31.04% | -16.00% |
| 2026 | $8.86 | $7.93 | $9.38 | 7.97% | -17.66% |
| 2027 | $6.4 | $5.42 | $7.63 | -22.03% | -27.77% |
| 2028 | $5.52 | $5.05 | $6.81 | -32.72% | -13.75% |
| 2029 | $10.08 | $7.15 | $12.71 | 22.72% | 82.61% |
| 2030 | $12.89 | $12.46 | $13.23 | 57.04% | 27.88% |
| 2031 | $10.6 | $9.43 | $12.54 | 29.06% | -17.77% |
| 2032 | $8.86 | $7.91 | $9.4 | 7.87% | -16.42% |
| 2033 | $7.47 | $7.34 | $7.61 | -8.97% | -15.69% |
Allogene Therapeutics stock forecast for next 5 days
| Date | Price Target | Change from previous day |
|---|---|---|
| 2023-02-03 | $8.47 | 3.20% |
| 2023-02-06 | $8.71 | 2.86% |
| 2023-02-07 | $8.89 | 2.05% |
| 2023-02-08 | $8.96 | 0.73% |
| 2023-02-09 | $8.86 | -1.09% |
Graph for Long term ALLO stock forecast
Allogene Therapeutics stock forecast 2023
Allogene Therapeutics stock price for 2023 Mar. will be $8.28. The highest price in 2023 will be $12.66, the lowest price will be $8.28, and the average price will be $10.62, which is +29.33% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2023 Mar. |
|---|---|---|---|---|
| 2023 Mar. | $8.28 | 0.86% | 0.86% | 0% |
| 2023 Apr. | $8.64 | 4.31% | 5.21% | 4.31% |
| 2023 May. | $9.18 | 6.32% | 11.86% | 10.90% |
| 2023 Jun. | $9.83 | 7.06% | 19.75% | 18.73% |
| 2023 Jul. | $10.46 | 6.40% | 27.41% | 26.32% |
| 2023 Aug. | $11.05 | 5.65% | 34.61% | 33.46% |
| 2023 Sep. | $11.61 | 5.01% | 41.35% | 40.14% |
| 2023 Oct. | $12.06 | 3.96% | 46.95% | 45.69% |
| 2023 Nov. | $12.40 | 2.79% | 51.05% | 49.76% |
| 2023 Dec. | $12.66 | 2.07% | 54.19% | 52.87% |
Allogene Therapeutics stock forecast 2024
In 2024, Allogene Therapeutics stock price will start from 12.86, and it will end at 12.58. It is about 53.17% from today. Also, Allogene Therapeutics stock is expected to drop -2.24% during 2024. The highest price in 2024 will be $13.1, the lowest price will be $12.44, and the average price will be $12.81, which is +56.03% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2024 Jan. |
|---|---|---|---|---|
| 2024 Jan. | $12.86 | 1.62% | 56.68% | 0.00% |
| 2024 Feb. | $13.01 | 1.17% | 58.52% | 1.17% |
| 2024 Mar. | $13.08 | 0.53% | 59.36% | 1.71% |
| 2024 Apr. | $13.10 | 0.15% | 59.60% | 1.86% |
| 2024 May. | $13.07 | -0.23% | 59.22% | 1.62% |
| 2024 Jun. | $12.99 | -0.66% | 58.17% | 0.95% |
| 2024 Jul. | $12.85 | -1.01% | 56.57% | -0.07% |
| 2024 Aug. | $12.71 | -1.14% | 54.79% | -1.21% |
| 2024 Sep. | $12.57 | -1.12% | 53.05% | -2.32% |
| 2024 Oct. | $12.45 | -0.90% | 51.67% | -3.19% |
| 2024 Nov. | $12.44 | -0.07% | 51.56% | -3.27% |
| 2024 Dec. | $12.58 | 1.06% | 53.17% | -2.24% |
Allogene Therapeutics stock forecast 2025
In 2025, Allogene Therapeutics stock price is expected to move from 12.62, and it will finish the year at 9.42. It is about 14.72% from today. Also, Allogene Therapeutics stock price is expected to decrease -25.34% during 2025. The highest price in 2025 will be $12.62, the lowest price will be $9.42, and the average price will be $10.76, which is +31.04% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2025 Jan. |
|---|---|---|---|---|
| 2025 Jan. | $12.62 | 0.32% | 53.65% | 0.00% |
| 2025 Feb. | $12.49 | -0.96% | 52.18% | -0.96% |
| 2025 Mar. | $12.19 | -2.45% | 48.44% | -3.39% |
| 2025 Apr. | $11.71 | -3.88% | 42.68% | -7.14% |
| 2025 May. | $11.16 | -4.77% | 35.88% | -11.57% |
| 2025 Jun. | $10.63 | -4.69% | 29.51% | -15.71% |
| 2025 Jul. | $10.22 | -3.90% | 24.45% | -19.00% |
| 2025 Aug. | $9.92 | -2.93% | 20.81% | -21.38% |
| 2025 Sep. | $9.71 | -2.10% | 18.28% | -23.03% |
| 2025 Oct. | $9.57 | -1.50% | 16.51% | -24.18% |
| 2025 Nov. | $9.47 | -0.95% | 15.40% | -24.90% |
| 2025 Dec. | $9.42 | -0.59% | 14.72% | -25.34% |
Allogene Therapeutics stock forecast 2026
In 2026, Allogene Therapeutics stock price is expected to move from 9.38, and it will finish the year at 7.93. It is about -3.41% from today. Furthermore, our analysis for Allogene Therapeutics stock prediction says that it is expected to go down -15.46% during 2026. The highest price in 2026 will be $9.38 and the lowest price will be $7.93. The average ALLO stock price during 2026 will be $8.86, which is +7.97% from the close price of 2023-02-02. Also, the expected average Allogene Therapeutics share price for 2026 is -17.66% lower than the average for 2025
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2026 Jan. |
|---|---|---|---|---|
| 2026 Jan. | $9.38 | -0.41% | 14.25% | 0.00% |
| 2026 Feb. | $9.35 | -0.36% | 13.84% | -0.36% |
| 2026 Mar. | $9.30 | -0.48% | 13.29% | -0.84% |
| 2026 Apr. | $9.24 | -0.68% | 12.52% | -1.51% |
| 2026 May. | $9.15 | -0.91% | 11.49% | -2.41% |
| 2026 Jun. | $9.05 | -1.15% | 10.21% | -3.54% |
| 2026 Jul. | $8.93 | -1.35% | 8.72% | -4.84% |
| 2026 Aug. | $8.79 | -1.57% | 7.01% | -6.34% |
| 2026 Sep. | $8.63 | -1.82% | 5.06% | -8.04% |
| 2026 Oct. | $8.43 | -2.24% | 2.71% | -10.10% |
| 2026 Nov. | $8.20 | -2.72% | -0.08% | -12.55% |
| 2026 Dec. | $7.93 | -3.33% | -3.41% | -15.46% |
Allogene Therapeutics stock forecast 2027
In 2027, Allogene Therapeutics stock price is expected to move from 7.63, and it will finish the year at 5.42. It is about -33.99% from today. Also, Allogene Therapeutics stock price is expected to decrease -28.96% during 2027. The highest price in 2027 will be $7.63, the lowest price will be $5.42, and the average price will be $6.4, which is -22.03% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2027 Jan. |
|---|---|---|---|---|
| 2027 Jan. | $7.63 | -3.80% | -7.08% | 0.00% |
| 2027 Feb. | $7.37 | -3.43% | -10.27% | -3.43% |
| 2027 Mar. | $7.11 | -3.47% | -13.38% | -6.78% |
| 2027 Apr. | $6.83 | -3.94% | -16.79% | -10.45% |
| 2027 May. | $6.56 | -3.97% | -20.10% | -14.01% |
| 2027 Jun. | $6.36 | -3.07% | -22.55% | -16.65% |
| 2027 Jul. | $6.21 | -2.41% | -24.41% | -18.65% |
| 2027 Aug. | $6.07 | -2.27% | -26.13% | -20.50% |
| 2027 Sep. | $5.92 | -2.42% | -27.91% | -22.42% |
| 2027 Oct. | $5.76 | -2.68% | -29.85% | -24.50% |
| 2027 Nov. | $5.59 | -2.98% | -31.93% | -26.75% |
| 2027 Dec. | $5.42 | -3.02% | -33.99% | -28.96% |
Allogene Therapeutics stock forecast 2028
In 2028, Allogene Therapeutics stock price is expected to move from 5.27, and it will finish the year at 6.81. It is about -17.06% from today. Also, Allogene Therapeutics stock price is expected to increase 29.17% during 2028. The highest price in 2028 will be $6.81, the lowest price will be $5.05, and the average price will be $5.52, which is -32.72% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2028 Jan. |
|---|---|---|---|---|
| 2028 Jan. | $5.27 | -2.73% | -35.79% | 0.00% |
| 2028 Feb. | $5.16 | -2.05% | -37.11% | -2.05% |
| 2028 Mar. | $5.10 | -1.32% | -37.94% | -3.34% |
| 2028 Apr. | $5.06 | -0.75% | -38.41% | -4.07% |
| 2028 May. | $5.05 | -0.17% | -38.51% | -4.23% |
| 2028 Jun. | $5.08 | 0.58% | -38.15% | -3.67% |
| 2028 Jul. | $5.17 | 1.75% | -37.07% | -1.98% |
| 2028 Aug. | $5.36 | 3.73% | -34.72% | 1.67% |
| 2028 Sep. | $5.68 | 6.05% | -30.77% | 7.83% |
| 2028 Oct. | $6.08 | 7.04% | -25.89% | 15.43% |
| 2028 Nov. | $6.46 | 6.21% | -21.28% | 22.60% |
| 2028 Dec. | $6.81 | 5.36% | -17.06% | 29.17% |
Allogene Therapeutics stock forecast 2029
In 2029, Allogene Therapeutics stock price is expected to move from 7.15, and it will finish the year at 12.71. It is about 54.84% from today. Also, Allogene Therapeutics stock price is expected to increase 77.83% during 2029. The highest price in 2029 will be $12.71, the lowest price will be $7.15, and the average price will be $10.08, which is +22.72% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2029 Jan. |
|---|---|---|---|---|
| 2029 Jan. | $7.15 | 4.98% | -12.93% | 0.00% |
| 2029 Feb. | $7.54 | 5.48% | -8.16% | 5.48% |
| 2029 Mar. | $8.03 | 6.50% | -2.18% | 12.34% |
| 2029 Apr. | $8.59 | 6.96% | 4.62% | 20.16% |
| 2029 May. | $9.21 | 7.17% | 12.13% | 28.77% |
| 2029 Jun. | $9.86 | 7.13% | 20.12% | 37.95% |
| 2029 Jul. | $10.51 | 6.62% | 28.07% | 47.08% |
| 2029 Aug. | $11.12 | 5.74% | 35.42% | 55.53% |
| 2029 Sep. | $11.65 | 4.76% | 41.87% | 62.94% |
| 2029 Oct. | $12.09 | 3.80% | 47.26% | 69.13% |
| 2029 Nov. | $12.44 | 2.93% | 51.58% | 74.09% |
| 2029 Dec. | $12.71 | 2.15% | 54.84% | 77.83% |
Allogene Therapeutics stock forecast 2030
In 2030, Allogene Therapeutics stock price is expected to move from 12.91, and it will finish the year at 12.57. It is about 53.14% from today. Also, Allogene Therapeutics stock price is expected to decrease -2.62% during 2030. The highest price in 2030 will be $13.23, the lowest price will be $12.46, and the average price will be $12.89, which is +57.04% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2030 Jan. |
|---|---|---|---|---|
| 2030 Jan. | $12.91 | 1.56% | 57.25% | 0.00% |
| 2030 Feb. | $13.06 | 1.18% | 59.11% | 1.18% |
| 2030 Mar. | $13.18 | 0.87% | 60.49% | 2.06% |
| 2030 Apr. | $13.23 | 0.43% | 61.17% | 2.50% |
| 2030 May. | $13.22 | -0.09% | 61.02% | 2.40% |
| 2030 Jun. | $13.13 | -0.65% | 59.97% | 1.73% |
| 2030 Jul. | $12.99 | -1.13% | 58.17% | 0.58% |
| 2030 Aug. | $12.82 | -1.28% | 56.14% | -0.71% |
| 2030 Sep. | $12.65 | -1.34% | 54.04% | -2.04% |
| 2030 Oct. | $12.50 | -1.18% | 52.22% | -3.20% |
| 2030 Nov. | $12.46 | -0.29% | 51.78% | -3.48% |
| 2030 Dec. | $12.57 | 0.89% | 53.14% | -2.62% |
Allogene Therapeutics stock forecast 2031
In 2031, Allogene Therapeutics stock price is expected to move from 12.54, and it will finish the year at 9.43. It is about 14.83% from today. Also, Allogene Therapeutics stock price is expected to decrease -24.83% during 2031. The highest price in 2031 will be $12.54, the lowest price will be $9.43, and the average price will be $10.6, which is +29.06% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2031 Jan. |
|---|---|---|---|---|
| 2031 Jan. | $12.54 | -0.24% | 52.77% | 0.00% |
| 2031 Feb. | $12.32 | -1.81% | 50.01% | -1.81% |
| 2031 Mar. | $11.90 | -3.40% | 44.90% | -5.15% |
| 2031 Apr. | $11.36 | -4.49% | 38.39% | -9.41% |
| 2031 May. | $10.82 | -4.75% | 31.82% | -13.72% |
| 2031 Jun. | $10.37 | -4.22% | 26.25% | -17.36% |
| 2031 Jul. | $10.02 | -3.33% | 22.05% | -20.11% |
| 2031 Aug. | $9.78 | -2.39% | 19.13% | -22.02% |
| 2031 Sep. | $9.62 | -1.60% | 17.23% | -23.26% |
| 2031 Oct. | $9.53 | -1.02% | 16.04% | -24.04% |
| 2031 Nov. | $9.47 | -0.64% | 15.30% | -24.53% |
| 2031 Dec. | $9.43 | -0.41% | 14.83% | -24.83% |
Allogene Therapeutics stock forecast 2032
In 2032, Allogene Therapeutics stock price is expected to move from 9.40, and it will finish the year at 7.91. It is about -3.69% from today. Also, Allogene Therapeutics stock price is expected to decrease -15.86% during 2032. The highest price in 2032 will be $9.4, the lowest price will be $7.91, and the average price will be $8.86, which is +7.87% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2032 Jan. |
|---|---|---|---|---|
| 2032 Jan. | $9.40 | -0.32% | 14.47% | 0.00% |
| 2032 Feb. | $9.36 | -0.36% | 14.05% | -0.36% |
| 2032 Mar. | $9.32 | -0.52% | 13.47% | -0.87% |
| 2032 Apr. | $9.25 | -0.75% | 12.62% | -1.61% |
| 2032 May. | $9.15 | -0.99% | 11.51% | -2.59% |
| 2032 Jun. | $9.04 | -1.22% | 10.15% | -3.77% |
| 2032 Jul. | $8.91 | -1.44% | 8.56% | -5.16% |
| 2032 Aug. | $8.76 | -1.69% | 6.72% | -6.76% |
| 2032 Sep. | $8.59 | -1.92% | 4.68% | -8.55% |
| 2032 Oct. | $8.40 | -2.25% | 2.32% | -10.61% |
| 2032 Nov. | $8.17 | -2.69% | -0.43% | -13.01% |
| 2032 Dec. | $7.91 | -3.28% | -3.69% | -15.86% |
Allogene Therapeutics stock forecast 2033
In 2033, Allogene Therapeutics stock price is expected to move from 7.61. The highest price in 2033 will be $7.61, the lowest price will be $7.34, and the average price will be $7.47, which is -8.97% from the close price of 2023-02-02.
| Date | Price Target | Change From Previous Month | Change from 2023-02-02 | Change from 2033 Jan. |
|---|---|---|---|---|
| 2033 Jan. | $7.61 | -3.79% | -7.34% | 0.00% |
| 2033 Feb. | $7.34 | -3.51% | -10.60% | -3.51% |
Historical price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| 2023-01-13 | $7.06 | $6.90 | $6.82 | $7.37 |
| 2023-01-17 | $6.95 | $7.04 | $6.81 | $7.14 |
| 2023-01-18 | $6.46 | $7.00 | $6.42 | $7.22 |
| 2023-01-19 | $6.37 | $6.37 | $6.08 | $6.45 |
| 2023-01-20 | $6.55 | $6.57 | $6.33 | $6.63 |
| 2023-01-23 | $6.86 | $6.60 | $6.41 | $7.09 |
| 2023-01-24 | $7.94 | $7.14 | $7.09 | $8.10 |
| 2023-01-25 | $7.99 | $7.77 | $7.27 | $8.10 |
| 2023-01-26 | $7.83 | $8.08 | $7.66 | $8.11 |
| 2023-01-27 | $7.92 | $7.85 | $7.81 | $8.44 |
| 2023-01-30 | $7.67 | $7.79 | $7.57 | $8.00 |
| 2023-01-31 | $7.72 | $7.68 | $7.56 | $7.93 |
| 2023-02-01 | $7.97 | $7.71 | $7.57 | $8.15 |
| 2023-02-02 | $8.21 | $8.15 | $8.04 | $8.40 |